4 Ways Strategic Site Selection Maximizes the Value Equation Expert Insights

4 Ways Strategic Site Selection Maximizes the Value Equation

In clinical trials, success hinges not just on protocol design and quality data but on…

cogres1March 4, 2026

Expedited Completion of a Complex Driving Study Collaboration Success Stories

Expedited Completion of a Complex Driving Study

Driving In the Fast Lane Discover how CRC leveraged our proprietary driving simulator to swiftly…

cogres1March 4, 2026

Next-Day Effects: Are Medications Leaving Drivers at Risk? Expert Insights

Next-Day Effects: Are Medications Leaving Drivers at Risk?

COMPLIANCE WITH 2017 FDA GUIDANCE FOR EVALUATING DRUG-IMPAIRED DRIVING Prescription and over-the-counter drugs can save…

cogres1March 4, 2026

World Mental Health Day 2024 Inside CRC

World Mental Health Day 2024

Celebrating Progress in Mental Health Care On World Mental Health Day, we reflect on the…

cogres1March 4, 2026

Two FDA Approvals to Advance Migraine Care Collaboration Success Stories

Two FDA Approvals to Advance Migraine Care

Proactive Mitigation to Support Program Success Learn how CRC’s proactive approach and real-time data oversight…

cogres1March 4, 2026

CRC Expands Medical Leadership Team with Appointment of Accomplished Medical Directors Breaking News

CRC Expands Medical Leadership Team with Appointment of Accomplished Medical Directors

Cognitive Research Corporation (CRC), a leading CNS-focused clinical research organization, proudly announces the addition of…

cogres1March 4, 2026

IND to FDA Approval: Acute Agitation in Schizophrenia and Bipolar Disorders Collaboration Success Stories

IND to FDA Approval: Acute Agitation in Schizophrenia and Bipolar Disorders

Overcoming Obstacles to Bring a New Standard of Care Discover how CRC’s approach helped a…

cogres1March 4, 2026

FDA Approval: Novel Formulation for Treatment of Schizophrenia Collaboration Success Stories

FDA Approval: Novel Formulation for Treatment of Schizophrenia

Driving FDA Approvals with Precision and Speed Discover how CRC’s expertise in clinical trial management…

cogres1March 4, 2026

Phase I Studies: On Time with Quality Data Collaboration Success Stories

Phase I Studies: On Time with Quality Data

Consistent Early Phase Milestone Achievement Backed by select partnerships with Phase I Specialty Units and…

cogres1March 4, 2026

Tight Timelines: The Biotech Existence Collaboration Success Stories

Tight Timelines: The Biotech Existence

First Patient In 6 Weeks from Written Award Learn how CRC partnered with an emerging…

cogres1March 4, 2026

CRC Appoints Dr. Tom Zoda as Chief Executive Officer Breaking News

CRC Appoints Dr. Tom Zoda as Chief Executive Officer

Cognitive Research Corporation (“CRC”), a leading Central Nervous System (CNS)-focused clinical research and drug development…

cogres1March 4, 2026